VistaGen Therapeutics, Inc.
GENETIC VARIANTS ASSOCIATED WITH RESPONSE TO TREATMENT OF NEUROLOGICAL DISORDERS
Last updated:
Abstract:
Method of treating depression, major depressive disorder, suicidal ideation and related disorders are described by administering L-4-chlorokynurenine (L-4-CI-KYN) to a subject based on their genotype.
Status:
Application
Type:
Utility
Filling date:
9 Apr 2020
Issue date:
30 Jun 2022